ArticleInternational journal of women's health2026
Assessment of the Burden of Maternal Hypertensive Disorders and the Quality of Care in China: A Systematic Analysis of the Global Burden of Disease (GBD) 2021 Study.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aims to analyze the disease burden and quality of care associated with maternal hypertensive disorders in China over time and across age groups from 1990 to 2021. Methods: This study employs statistical methods, including joinpoint regression analysis, decomposition analysis, age-period-cohort analysis, and the quality-of-care index, to assess the disease burden of maternal hypertensive disorders in China between 1990 and 2021. It uses an ARIMA model to forecast the disease burden for the period 2022-2035. Results: Compared with 1990, the decline in the number of deaths, death rate, number of DALYs, and DALYs rate in 2021 was over 80% in each case, at 89.66%, 87.50%, 84.97% and 82.97%, respectively; the decline in the number and rate of prevalence, as well as the number and rate of incidence, ranged between 35% and 45%. The burden of disease has shifted from the 20-24 age group to the 30-34 age group (peak in number of cases) or the 25-29 age group (peak in rates). ARIMA forecasts that these rates will continue to decline through to 2035, although the rate of decline in incidence and prevalence will slow. The quality-of-care index rose steadily from 2003 to 2021. Conclusion: The overall burden of maternal hypertensive disorders in China is declining. Based on the observed epidemiological trends: the quality of care is relatively low among both younger and older age groups; blood pressure management across the entire reproductive lifespan could be optimized in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.